Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits

BACKGROUND: Hospitalized patients with COVID-19 demonstrate a higher risk of developing thromboembolism. Anticoagulation (AC) has been proposed for high-risk patients, even without confirmed thromboembolism. However, benefits and risks of AC are not well assessed due to insufficient clinical data. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Bo, Gutierrez, Victor Perez, Carlos, Alex, Hoge, Gregory, Pillai, Anjana, Kelly, J. Daniel, Menon, Vidya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087886/
https://www.ncbi.nlm.nih.gov/pubmed/33933168
http://dx.doi.org/10.1186/s40364-021-00283-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087886/
https://www.ncbi.nlm.nih.gov/pubmed/33933168
http://dx.doi.org/10.1186/s40364-021-00283-y

Ejemplares similares